Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose.

H Kocak; U Yakupoglu; G Uslu Karatas; A Yavuz; A Gurkan; O Erdogan; F F Ersoy; G Yakupoglu; A Demirbas; M Tuncer

doi:10.1016/j.transproceed.2005.07.033

Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose.

Identifier:nobleid.org/w1/20260515/8430DDBB

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8430DDBB.svg?ark=w1%2F20260515%2F8430DDBB)](https://nobleid.org/work/w1/20260515/8430DDBB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose.

Identifier:nobleid.org/w1/20260515/8430DDBB

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8430DDBB.svg?ark=w1%2F20260515%2F8430DDBB)](https://nobleid.org/work/w1/20260515/8430DDBB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work